You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for ORTHO-NOVUM 1/50 28


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for ORTHO-NOVUM 1/50 28

Vendor Vendor Homepage Vendor Sku API Url
BenchChem ⤷  Get Started Free B1200416 ⤷  Get Started Free
THE BioTek ⤷  Get Started Free bt-1540714 ⤷  Get Started Free
RR Scientific ⤷  Get Started Free R5270913 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for ORTHO-NOVUM 1/50 28

Last updated: August 10, 2025


Introduction

The contraceptive combination pill ORTHO-NOVUM 1/50 28 offers a widely prescribed oral hormonal formulation containing ethinyl estradiol (EE) and norethindrone. Ensuring reliable and compliant supply of its active pharmaceutical ingredients (APIs)—ethinyl estradiol and norethindrone—is vital for pharmaceutical manufacturers and healthcare providers. This analysis explores the primary sources, manufacturers, and considerations for sourcing these APIs on a bulk scale.


Overview of API Components

Ethinyl Estradiol (EE): A potent synthetic estrogen synthesized from estradiol derivatives, used broadly in combined oral contraceptives. Its production involves complex chemical synthesis routes demanding high purity and stringent quality controls.

Norethindrone: A synthetic progestin derived through complex organic synthesis. It is crucial for its hormonal activity and stability, requiring meticulous manufacturing processes.

Successful procurement of high-quality APIs hinges on identifying reputable manufacturers with validated GMP compliance, consistent purity standards, and supply reliability.


Major Sources of Ethinyl Estradiol

  1. Selleck Chemicals/Bio-Derivative Suppliers

    Several suppliers, including Selleck Chemicals and Bio-Derivative manufacturers, provide bulk EE suitable for pharmaceutical use. These sources often cater to research and commercial manufacturing, ensuring high-grade APIs with rigorous quality control.

  2. CordenPharma (part of International Chemical Investors Group)

    CordenPharma specializes in complex active pharmaceutical ingredients, including synthetic estrogens like EE. They maintain cGMP compliance and produce APIs adhering to pharmacopeial standards (USP, EP). Their global facilities enable reliable supply chains.

  3. Generics & API Manufacturers in India and China

    India’s major API manufacturers such as Dr. Reddy’s Laboratories, Hetero Labs, and Sun Pharmaceutical Industries have significant capabilities in synthesizing EE at scale. Similarly, Chinese companies like Zhejiang Medicine Co., Ltd., supply pharmaceutical-grade EE globally, primarily targeting generic medicinal product markets.

  4. European and North American Suppliers

    Companies such as GVK Biosciences and Synthesis & BioChem hold GMP certifications for EE, often designated for high-value pharmaceutical applications. Their focus is on strict quality and regulatory compliance, suitable for U.S., European, and other regulated markets.


Major Sources of Norethindrone

  1. CordenPharma and Patheon

    Leading API producers such as CordenPharma and Patheon offer bulk norethindrone, with manufacturing facilities validated for GMP standards. Their production pipeline ensures the supply of high-purity APIs suitable for use in contraceptive formulations including ORTHO-NOVUM 1/50.

  2. Indian API Manufacturers

    Companies like Laurus Labs and Cipla are major suppliers of norethindrone, consistently meeting international quality benchmarks. Their large-scale facilities support stable supply chains at competitive pricing.

  3. Chinese API Suppliers

    Chinese firms like Zhejiang Hisun Pharmaceutical Co., Ltd. and Shanghai Sunway Biotech produce norethindrone conforming to pharmacopeial standards, with export licenses supporting global distribution.

  4. Estate-Grade API Suppliers in Europe and North America

    These include companies like Fermion and Fareva, recognized for producing pharma-grade norethindrone with validated manufacturing processes aligning with stringent regulatory standards.


Key Sourcing Considerations

Regulatory Compliance and GMP Certification

Choosing API sources with GMP compliance is essential to meet regulatory requirements for pharmaceutical products in major markets. Validation of manufacturing practices, batch-to-batch consistency, and adherence to USP/EP standards ensure product safety and efficacy.

Quality Assurance and Purity Standards

APIs destined for oral contraceptives like ORTHO-NOVUM 1/50 must meet high purity standards, typically exceeding 99%. Suppliers should provide comprehensive analytical data, including HPLC purity profiles, residual solvents, heavy metals testing, and stability data.

Supply Chain Reliability

Long-term supply agreements with established manufacturers mitigate risks of shortages, price fluctuations, and regulatory delays. Multisource strategies are advisable to safeguard against geopolitical or production disruptions.

Cost Effectiveness

While quality takes precedence, competitive pricing is critical, particularly for generics and high-volume production. Indian and Chinese manufacturers often offer cost advantages with comparable quality, subject to thorough qualification.


Emerging Trends & Market Dynamics

  • API Synthesis Innovation: Advances in green chemistry and process optimization are improving yields and reducing environmental impact, influencing supplier selection.

  • Regulatory Scrutiny: Increasing international regulatory enforcement emphasizes transparency and validation of API manufacturing, favoring suppliers with proven compliance histories.

  • Supply Chain Resilience: The COVID-19 pandemic stimulated diversification of API sources, leading to a broader global supplier footprint for estrogenic and progestogenic APIs.


Summary of Top API Suppliers for ORTHO-NOVUM 1/50

API Component Leading Suppliers Regions Certifications Notes
Ethinyl Estradiol CordenPharma, GVK Biosciences, Zhejiang Medicine Europe, India, China GMP, DMF, USDMF Focus on high purity, regulatory compliance
Norethindrone CordenPharma, Laurus Labs, Zhejiang Hisun Europe, India, China GMP, CEP/EDQM Commercial-scale production, stability

Key Takeaways

  • The bulk API market for ORTHO-NOVUM 1/50 primarily involves established suppliers from Europe, North America, India, and China.
  • Reputable manufacturers with GMP certification and robust quality assurance frameworks are vital for consistent, regulatory-compliant APIs.
  • Diversified sourcing minimizes risks amidst geopolitical, environmental, or supply constraints.
  • Ongoing advancements in API synthesis and manufacturing contribute to cost-effective, high-quality supply options.
  • Due diligence, including rigorous qualification protocols, ensures APIs meet pharmacopeial standards required for contraceptive products.

FAQs

1. What are the major API manufacturing regions for ORTHO-NOVUM 1/50?
Major regions include Europe, North America, India, and China, each hosting key manufacturers capable of supplying high-quality ethinyl estradiol and norethindrone.

2. How do I ensure the quality of bulk APIs for contraceptives?
Verify GMP certification, review detailed analytical data, validate batch consistency, and conduct third-party testing when possible.

3. Are there geopolitical risks associated with sourcing from China or India?
Yes, supply chains might face disruptions due to regulatory changes, tariffs, or geopolitical tensions. Diversifying suppliers mitigates these risks.

4. What regulatory standards should suppliers meet?
Suppliers should comply with GMP standards, possess valid DMFs or CEPs, and adhere to USP, EP, or other regional pharmacopeial standards.

5. How can manufacturers reduce costs while maintaining quality?
Partnering with reputable Indian or Chinese API manufacturers, leveraging scale, and optimizing supply logistics can lower costs without compromising quality.


References

  1. [1] U.S. Pharmacopeia. "Ethinyl Estradiol Monograph." US Pharmacopeia, 2022.
  2. [2] European Pharmacopoeia. "Norethindrone Monograph," 10th Edition, 2022.
  3. [3] CordenPharma official website. Product portfolio and GMP compliance documentation.
  4. [4] Dr. Reddy’s Laboratories Annual Report, 2022.
  5. [5] Global API Market Insights, IQVIA, 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.